NWK Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
NWK Group's LLY Position: Q1 2026 in Review
NWK Group reduced its Eli Lilly (LLY) stake by 1.3% in Q1 2026, selling an estimated $196K and leaving 15,174 shares worth $14M. The position accounts for 5.36% of the portfolio, ranked #5.
NWK Group first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $16.5M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- NWK Group held 15,174 shares of Eli Lilly worth $14M as of Q1 2026.
- NWK Group sold 193 Eli Lilly shares in Q1 2026, an estimated $196K.
- Eli Lilly made up 5.36% of NWK Group's portfolio in Q1 2026, its #5 holding.
- NWK Group first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
- NWK Group's Eli Lilly position peaked at $16.5M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on NWK Group's 13F filing for Q1 2026, filed 7 May 2026.